The Microbiome Therapeutics Innovation Group (MTIG) is a Washington, D.C.-based trade association for companies working on microbiome-based therapies. MTIG lobbies Congress mainly on federal budget and appropriations, and on medical and research issues—seeking funding and education about the microbiome and federal research opportunities, plus changes to Food and Drug Administration rules. It reports modest spending and uses The Conafay Group for lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOSH NARROW
The latest disclosures for this client.
THE CONAFAY GROUP, LLC
Q3THE CONAFAY GROUP, LLC
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE CONAFAY GROUP, LLC
mr DARIN L GARDNER
THE CONAFAY GROUP, LLC
THE CONAFAY GROUP, LLC
Q2THE CONAFAY GROUP, LLC
Q1THE CONAFAY GROUP, LLC
Q4THE CONAFAY GROUP, LLC
Q3THE CONAFAY GROUP, LLC
Q2THE CONAFAY GROUP, LLC
Q1